Rankings
▼
Calendar
TKNO FY 2023 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$133M
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$37M
-11.4% YoY
Gross Profit
$10M
28.1% margin
Operating Income
-$36M
-96.9% margin
Net Income
-$37M
-100.3% margin
EPS (Diluted)
$-1.16
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$27M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$129M
Total Liabilities
$39M
Stockholders' Equity
$90M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$37M
$41M
-11.4%
Gross Profit
$10M
$17M
-41.1%
Operating Income
-$36M
-$50M
+28.4%
Net Income
-$37M
-$47M
+22.5%
← Q4 2022
All Quarters
Q1 2023 →